SUMMA RX LABORATORIES INC
10-Q, EX-27, 2000-09-26
PHARMACEUTICAL PREPARATIONS
Previous: SUMMA RX LABORATORIES INC, 10-Q, 2000-09-26
Next: SUMMA RX LABORATORIES INC, 10QSB, 2000-09-26



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q
FOR THE QUARTER ENDED JULY 31, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FORM 10-Q FOR THE QUARTER ENDED JULY 31, 1997.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          APR-30-1998
<PERIOD-START>                             MAY-01-1997
<PERIOD-END>                               JUL-31-1997
<CASH>                                         506,951
<SECURITIES>                                         0
<RECEIVABLES>                                  281,407
<ALLOWANCES>                                    41,650
<INVENTORY>                                    171,682
<CURRENT-ASSETS>                               930,403
<PP&E>                                       1,389,446
<DEPRECIATION>                                 427,683
<TOTAL-ASSETS>                               1,903,989
<CURRENT-LIABILITIES>                        1,060,186
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        35,974
<OTHER-SE>                                     612,829
<TOTAL-LIABILITY-AND-EQUITY>                 1,903,989
<SALES>                                      1,027,442
<TOTAL-REVENUES>                             1,027,442
<CGS>                                          465,112
<TOTAL-COSTS>                                  823,357
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               9,000
<INCOME-PRETAX>                                195,085
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            195,085
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   195,085
<EPS-BASIC>                                        .05
<EPS-DILUTED>                                        0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission